newsfilter
← Latest News
GlobeNewswire·

NightHawk Biosciences Provides 2022 Year End Business Update

DURHAM, N.C., March 31, 2023 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE:NHWK), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today